GEOMC Co., Ltd. v. Calmare Therapeutics Inc., No. 17-3502-CV (2d Cir 2018)

Obtaining a seldom-granted remedy, persuaded the Second Circuit to stay a $10.4 million final judgment pending appeal, which ultimately was successful.